A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS
Neurol Neuroimmunol Neuroinflamm
.
2019 Dec 5;7(1):e657.
doi: 10.1212/NXI.0000000000000657.
Print 2020 Jan.
PMID:
31806686
PMCID:
PMC6935840
DOI:
10.1212/NXI.0000000000000657
No abstract available
Publication types
Published Erratum